BioSpace News Archive

– Baseline data from the BUTTERFLY observational study provide initial validation of standard measures of cognition (BSID-III and WPPSI-IV) for use in evaluating non-seizure comorbidities in people with Dravet syndrome – – The current design for the ongoing MONARCH Phase 1/2a study to assess both single and multiple ascending doses of STK-001 in children and adolescents with Dravet syndrome will be presented –

Sarah Cannon to Present Latest in Blood Cancer Research at the 62 nd ASH Annual Meeting & Exposition

In an attempt to regulate the cost of healthcare, high cost of drugs, especially biologics, is increasingly becoming an issue.

PharmaEngine, Inc. announced that it has entered into a Collaboration and License Agreement with UK-based Sentinel Oncology Limited for advancing the new drug development of SOL-578, a Checkpoint Kinase 1 inhibitor, under which PharmaEngine will fund the IND enabling studies for SOL-578.

Body Doctor specializes in eye-care, eyelid hygiene products and have transformed the market for eye compresses and continue establishing a pedigree of bringing innovation to the sector with an antibacterial fabric thanks to the partnership with Polygiene®.